NAPWHA, ASHM, AFAO, May 2022 From 1st July, people with HIV who are ineligible for Medicare, and who previously received HIV medication through compassionate access schemes, will be required to transition to alternative access arrangements in order to receive government-funded treatment*. Option 1: individuals will need to engage in care with a public hospital-based physician and have their...
nam/aidsmap, 14 April 2022 Perceived irrelevance, lack of awareness, problems with access, side effects, negative social impacts, and concerns about lack of STI protection, effectiveness and adherence are the most common reasons for not using PrEP among gay and bisexual men in Australia. This is according to a study recently published in the journal Behavioral Medicine which analysed reasons for...
Lowe, J. and Black, K.I. (2021), Aust N Z J Obstet Gynaecol, 61: 325-327. Female genital cosmetic surgery (FGCS) is a relatively new and highly controversial surgical field where sociocultural influences and medicine collide. Procedures under this umbrella term include vaginoplasty, hymenoplasty, and labiaplasty. Labiaplasty is the most common of these and typically involves procedures to reduce...
Disparities in characteristics in accessing public Australian sexual health services between Medicare‐eligible and Medicare‐ineligible men who have sex with men Australian and New Zealand Journal of Public Health Anysha M. Walia, Christopher K. Fairley, Catriona S. Bradshaw, Marcus Y. Chen, Eric P.F. Chow First published: 31 August 2020 Abstract: Objectives: Accessible health services are a key...
SBS News, 26th April 2020 Vulnerable pregnant women could lose access to abortion throughout Australia because of increased financial hardship caused by the coronavirus pandemic, reproductive health providers have warned. A combination of widespread job losses, differing abortion laws around the country, and patchy access to Medicare, could mean more women need financial assistance to terminate...
Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...